Please assess the completion status of the following clinical trial:

Trial Title: Aspirin/Folate Prevention of Large Bowel Polyps

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. One neoplastic polyp removed within three months of study entry or within 16 months of study entry if over 1 cm in size or if subject has had a lifetime history of at least two polyps, with the entire large bowel seen by colonoscopy to be free of further polyps within 3 months of entry.~2. An ability and willingness to follow the study protocol, as indicated by the subject's giving informed consent to participate.~3. Good general health, with no severely debilitating diseases or active malignancy that might compromise the patient's ability to complete the study.~4. Anticipated colonoscopic follow-up three years after the qualifying colonoscopy.~5. Age between 21 and 80 years at the time of the intake colonoscopy.~6. For women of childbearing potential, agreement to use effective birth control for the duration of the study.~7. Intent not to take aspirin or aspirin-containing products, NSAIDs or folic acid for the length of the study unless required by a physician.~8. Not randomized previously or currently in a chemoprevention trial, except for the: Nutritional Prevention of Large Bowel Polyps Study (Polyps Prevention Study I); and brief participation in the VA Cooperative Study with no continuing involvement.~Exclusion Criteria:~1. Invasive carcinoma in any colonic polyp removed.~2. Familial colonic polyposis syndromes.~3. Ulcerative colitis or Crohn's disease.~4. Malabsorption syndrome (e.g. pancreatic insufficiency).~5. Large bowel resection for any reason.~6. Diagnosed narcotic or alcohol dependence~7. Contraindication to aspirin use, including:~   1. documented peptic ulcer disease in the past 20 years~  2. aspirin sensitivity~  3. bleeding diathesis, including hemorrhagic stroke~8. Likelihood of NSAID use~   1. recurring arthritis or other musculo-skeletal problems~  2. frequent NSAID use in 5 years preceding~  3. history of stroke or TIAs~  4. history of angina or myocardial infarction~  5. desire to take aspirin for the prevention of cardiovascular disease~9. Required or contraindicated folic acid use pernicious anemia or folic acid deficiency~10. Pregnancy or lactation.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 80 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).